• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菊粉、胆碱和水飞蓟宾治疗便秘型肠易激综合征——随机病例对照研究

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study.

作者信息

Bărboi Oana-Bogdana, Chirilă Ioan, Ciortescu Irina, Anton Carmen, Drug Vasile-Liviu

机构信息

Department of Gastroenterology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.

Institute of Gastroenterology and Hepatology, 'Saint Spiridon' Hospital, 700111 Iasi, Romania.

出版信息

J Clin Med. 2022 Apr 17;11(8):2248. doi: 10.3390/jcm11082248.

DOI:10.3390/jcm11082248
PMID:35456341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027095/
Abstract

(1) Background: Irritable bowel syndrome (IBS) is a common disease, with multiple pathophysiological mechanisms involved. A single treatment for all the patients with IBS is not possible. Prebiotics may have a beneficial effect on IBS patients with constipation. (2) Methods: A randomized cross-over case-control study was conducted, including patients with IBS and constipation (IBS-C), who were randomized into two groups receiving a specific constipation diet with or without a food supplement containing inulin, choline and silymarin (Stoptoxin®, Fiterman Pharma, Iasi, Romania). Patients were evaluated at baseline, after four and eight weeks, using a questionnaire to assess IBS symptoms. (3) Results: 51 IBS-C patients were included, of which 47 patients finished the trial (33 women, mean age 52.82 years). Adding Stoptoxin® to a diet for constipation brought extra benefits. Abdominal pain severity improved by 68.3% after the diet and Stoptoxin® (p = 0.004) and abdominal bloating severity parameter improved by 34.8% (p = 0.040). The stool number per week and the stool consistency according to the Bristol scale were improved, but without statistical significance between groups (p > 0.05). (4) Conclusions: The combination of inulin, choline and silymarin associated with a specific-constipation diet had obvious clinical beneficial effects on IBS-C patients in terms of bowel movement, abdominal pain and bloating.

摘要

(1) 背景:肠易激综合征(IBS)是一种常见疾病,涉及多种病理生理机制。对所有IBS患者采用单一治疗方法是不可能的。益生元可能对便秘型IBS患者有有益作用。(2) 方法:进行了一项随机交叉病例对照研究,纳入便秘型IBS(IBS-C)患者,这些患者被随机分为两组,一组接受特定的便秘饮食,另一组接受含菊粉、胆碱和水飞蓟宾的食物补充剂(Stoptoxin®,Fiterman Pharma,罗马尼亚雅西)。在基线、四周和八周后,使用问卷评估IBS症状对患者进行评估。(3) 结果:纳入51例IBS-C患者,其中47例完成试验(33名女性,平均年龄52.82岁)。在便秘饮食中添加Stoptoxin®带来了额外益处。饮食加Stoptoxin®后腹痛严重程度改善了68.3%(p = 0.004),腹胀严重程度参数改善了34.8%(p = 0.040)。每周排便次数和根据布里斯托量表评估的大便稠度有所改善,但两组间无统计学意义(p > 0.05)。(4) 结论:菊粉、胆碱和水飞蓟宾与特定便秘饮食联合使用,在排便、腹痛和腹胀方面对IBS-C患者有明显的临床有益效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/b081e18a61f0/jcm-11-02248-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/4f684a7ea43a/jcm-11-02248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/122388ec962e/jcm-11-02248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/5f11e7a576eb/jcm-11-02248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/9d2bee6ea7df/jcm-11-02248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/947ccaa1da37/jcm-11-02248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/03fdffb0c378/jcm-11-02248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/ca20b48e4a8f/jcm-11-02248-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/b081e18a61f0/jcm-11-02248-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/4f684a7ea43a/jcm-11-02248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/122388ec962e/jcm-11-02248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/5f11e7a576eb/jcm-11-02248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/9d2bee6ea7df/jcm-11-02248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/947ccaa1da37/jcm-11-02248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/03fdffb0c378/jcm-11-02248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/ca20b48e4a8f/jcm-11-02248-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e8/9027095/b081e18a61f0/jcm-11-02248-g008.jpg

相似文献

1
Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study.菊粉、胆碱和水飞蓟宾治疗便秘型肠易激综合征——随机病例对照研究
J Clin Med. 2022 Apr 17;11(8):2248. doi: 10.3390/jcm11082248.
2
[Using a multicomponent functional food in IBS patients with constipation a comparative controlled study].[在便秘型肠易激综合征患者中使用多成分功能性食品的一项比较对照研究]
Vopr Pitan. 2016;85(2):84-91.
3
[Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome].[新开发的基于康普茶的特殊食品治疗便秘型肠易激综合征的疗效]
Vopr Pitan. 2022;91(5):95-104. doi: 10.33029/0042-8833-2022-91-5-95-104. Epub 2022 Aug 30.
4
Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.腹泻在评估肠易激综合征临床研究中便秘的重要性。
J Clin Gastroenterol. 2011 Oct;45(9):790-3. doi: 10.1097/MCG.0b013e3182053cea.
5
[Dry jelly concentrate with vitamins and dietary fiber in patients with IBS with constipation: a comparative controlled study].[含维生素和膳食纤维的干果冻浓缩物用于便秘型肠易激综合征患者:一项对照比较研究]
Vopr Pitan. 2015;84(6):83-91.
6
Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.利那洛肽治疗便秘型肠易激综合征和慢性便秘患者的疗效:一项荟萃分析。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1084-1092.e3; quiz e68. doi: 10.1016/j.cgh.2013.04.032. Epub 2013 May 2.
7
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.低 FODMAP 饮食可减轻肠易激综合征症状。
Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25.
8
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.替加色罗用于治疗肠易激综合征和慢性便秘。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003960. doi: 10.1002/14651858.CD003960.pub3.
9
Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.中药治疗便秘型肠易激综合征的疗效:一项随机对照试验。
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1946-54.e1. doi: 10.1016/j.cgh.2015.06.022. Epub 2015 Jun 29.
10
Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins for the Management of Constipation-Predominant Irritable Bowel Syndrome in Females: A Randomized Pilot Study.富含菊粉和维生素的康普茶饮品治疗女性便秘型肠易激综合征的疗效评估:一项随机试点研究。
Curr Dev Nutr. 2023 Nov 24;7(12):102037. doi: 10.1016/j.cdnut.2023.102037. eCollection 2023 Dec.

引用本文的文献

1
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.肠易激综合征中的肠道菌群失调:关于与疾病亚型的相关性及新治疗意义的叙述性综述
Microorganisms. 2023 Sep 22;11(10):2369. doi: 10.3390/microorganisms11102369.
2
Global Trends in Research of Pain-Gut-Microbiota Relationship and How Nutrition Can Modulate This Link.全球疼痛-肠道-微生物群关系研究趋势及营养如何调节这种关联
Nutrients. 2023 Aug 24;15(17):3704. doi: 10.3390/nu15173704.
3
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.

本文引用的文献

1
The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.通过映射到肠易激综合征患者的 EQ-5D-5L,对 IBS-QoL 的偏好单指数进行估计。
Qual Life Res. 2022 Apr;31(4):1209-1221. doi: 10.1007/s11136-021-02995-y. Epub 2021 Sep 21.
2
Best management of irritable bowel syndrome.肠易激综合征的最佳管理
Frontline Gastroenterol. 2020 May 28;12(4):303-315. doi: 10.1136/flgastro-2019-101298. eCollection 2021.
3
Romanian Guidelines for Nonpharmacological Therapy of IBS.
便秘型肠易激综合征(IBS-C):不同营养模式对肠道菌群失调和症状的影响。
Nutrients. 2023 Mar 28;15(7):1647. doi: 10.3390/nu15071647.
罗马尼亚肠易激综合征非药物治疗指南。
J Gastrointestin Liver Dis. 2021 Jun 18;30(2):291-306. doi: 10.15403/jgld-3581.
4
Adults living with irritable bowel syndrome (IBS): A qualitative systematic review.成人肠易激综合征(IBS)患者:一项定性系统评价。
J Psychosom Res. 2021 Jan;140:110289. doi: 10.1016/j.jpsychores.2020.110289. Epub 2020 Nov 13.
5
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.饮食中胆碱的生物利用度与其对肠道微生物组成的关系,及其对人类疾病的调节作用。
Nutrients. 2020 Aug 5;12(8):2340. doi: 10.3390/nu12082340.
6
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.全球功能性胃肠病的流行情况和负担:罗马基金会全球研究结果。
Gastroenterology. 2021 Jan;160(1):99-114.e3. doi: 10.1053/j.gastro.2020.04.014. Epub 2020 Apr 12.
7
Changes in stool frequency following chicory inulin consumption, and effects on stool consistency, quality of life and composition of gut microbiota.食用菊苣菊粉后大便频率的变化,及其对大便稠度、生活质量和肠道微生物群组成的影响。
Food Hydrocoll. 2019 Nov;96:688-698. doi: 10.1016/j.foodhyd.2019.06.006.
8
An Overview of Fiber and Fiber Supplements for Irritable Bowel Syndrome.肠易激综合征的膳食纤维及纤维补充剂概述
Gastroenterol Hepatol (N Y). 2019 Jul;15(7):387-389.
9
The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy.微生物群与肠易激综合征——病理生理学、当前研究及未来治疗的综述
Front Microbiol. 2019 Jun 10;10:1136. doi: 10.3389/fmicb.2019.01136. eCollection 2019.
10
Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV.功能性消化不良与肠易激综合征:超越罗马IV标准
Dig Dis. 2017;35 Suppl 1:14-17. doi: 10.1159/000485408. Epub 2018 Feb 8.